Helen of Troy experienced a 3.4% drop in net sales and posted a net loss due to asset impairment charges. Adjusted EPS remained positive, supported by the acquisition of Olive & June and improved direct-to-consumer performance.

Helen of Troy posted a net loss of $308.6 million for Q2 FY2026, primarily driven by $326.4 million in non-cash asset impairment charges. Revenue declined 8.9% YoY to $431.8 million, and adjusted EPS was $0.59. Gross margin and operating margin also contracted versus the prior year.

Helen of Troy experienced a 10.8% revenue decline and a $450.7M net loss in Q1 2026, mainly due to non-cash asset impairment charges. However, adjusted EPS remained positive, reflecting operational resilience in parts of the business.

Helen of Troy Limited reported fourth quarter fiscal 2025 results with a consolidated net sales decline of 0.7% to $485.9 million. GAAP diluted EPS grew by 24.0% to $2.22, while adjusted diluted EPS declined by 4.9% to $2.33. The company recognized significant non-cash asset impairment charges during the quarter.

Helen of Troy reported a 3.4% decrease in consolidated net sales revenue to $530.7 million. GAAP diluted EPS was $2.17, while adjusted diluted EPS was $2.67. The company saw gross profit margin expansion of 90 basis points and adjusted operating margin expansion of 30 basis points. The acquisition of Olive & June was completed subsequent to the quarter's end.

Helen of Troy reported a 3.5% decrease in consolidated net sales to $474.2 million, but still exceeded expectations. GAAP diluted EPS was $0.74, while adjusted diluted EPS was $1.21. The company reaffirmed its annual outlook for net sales, adjusted EPS, and adjusted EBITDA.

Helen of Troy reported a 12.2% decrease in consolidated net sales to $416.8 million, with GAAP diluted EPS at $0.26 and Adjusted diluted EPS at $0.99. Gross profit margin improved by 330 basis points, while operating margin declined. The company updated its fiscal 2025 outlook, lowering sales and earnings expectations due to internal and external challenges.

Helen of Troy reported a 1.0% increase in consolidated net sales revenue to $489.2 million. GAAP diluted EPS grew by 19.3% to $1.79, and adjusted diluted EPS increased by 21.9% to $2.45. The company experienced gross profit margin improvement of 570 basis points and adjusted EBITDA margin expansion of 410 basis points.

Helen of Troy reported a slight decrease in consolidated net sales revenue of 1.6% to $549.6 million. However, the company saw improvements in gross profit margin and operating margin, alongside a GAAP diluted EPS of $3.19 and adjusted diluted EPS of $2.79. The company is narrowing its full year outlook for net sales and GAAP diluted EPS, while lowering adjusted EBITDA and maintaining free cash flow and net leverage ratio reduction.

Helen of Troy reported a 5.7% decrease in consolidated net sales revenue, but achieved a 420 basis points increase in gross profit margin. The company is maintaining its full year outlook and is on track with its Project Pegasus restructuring plan. An agreement was reached with Brian Grass to remain as CFO.

Helen of Troy Limited reported first quarter fiscal 2024 results, with consolidated net sales declining by 6.6%. However, the company saw improvements in gross profit margin and operating margin. Free cash flow also showed a significant increase. The company reiterated its full fiscal year outlook for sales, adjusted EPS, margin expansion, and free cash flow.

Helen of Troy reported a 16.7% decrease in consolidated net sales revenue and a decrease in GAAP diluted EPS from $1.64 to $1.50. The company's performance was better than expected, with adjusted operating margin expansion and strong free cash flow.

Helen of Troy reported a 10.6% decrease in consolidated net sales and a 26.1% decrease in core adjusted diluted EPS for Q3 2023. However, the company exceeded expectations due to significant improvements in gross margin and cash flow, as well as efforts to reduce inventory levels.

Helen of Troy Limited reported second quarter fiscal 2023 results with consolidated net sales growth of 9.7% and core net sales growth of 11.1% from fiscal 2022. GAAP diluted EPS was $1.28, and core adjusted diluted EPS was $2.27, a decline of 14.3% from fiscal 2022. The company announced Project Pegasus, a restructuring plan targeting annualized savings of $75-$85 million and updated fiscal 2023 net sales and diluted EPS outlook.

Helen of Troy reported a 6.1% decrease in consolidated net sales to $508.1 million and a GAAP diluted EPS of $1.02. Core adjusted diluted EPS was $2.41, a 27.2% decrease from the previous year. The company has updated its fiscal 2023 net sales and diluted EPS outlook, expecting consolidated net sales to be $2.150-$2.200 billion and consolidated diluted EPS to be $6.51-$7.11.

Helen of Troy's Q4 2022 results significantly outperformed expectations, with strong growth in each business segment. Consolidated net sales revenue increased by 14.3% to $582.0 million, and core adjusted diluted EPS grew by 76.8% to $2.51. The company also provided a positive outlook for fiscal 2023, expecting continued top and bottom-line growth.

Helen of Troy Limited reported its Q3 Fiscal 2022 results, with consolidated net sales declining by 2.0% but core business net sales increasing by 0.4%. GAAP diluted EPS was $3.10, while core adjusted diluted EPS grew by 3.0% to $3.72. The company raised its fiscal 2022 diluted EPS and net sales outlook.

Helen of Troy reported a decrease in consolidated net sales of 10.5% to $475.2 million, a decrease in GAAP diluted EPS to $2.11, and a decrease in adjusted diluted EPS of 29.7% to $2.65. Despite these declines, the company raised its fiscal 2022 diluted EPS and net sales outlook.

Helen of Troy's Q4 2021 saw a 15.1% increase in consolidated net sales, reaching $509.4 million, despite a $15 million adverse impact from Winter Storm Uri. Organic business net sales grew by 12.2%, and leadership brand net sales increased by 20.2%. GAAP diluted EPS was $0.90, including an impairment charge of $0.30, while adjusted diluted EPS was $1.57.

Helen of Troy reported an exceptional third quarter with a 34.3% increase in consolidated net sales and a 20.5% growth in adjusted EPS. The company's performance was driven by strong momentum across all business segments and channels. They are also initiating fiscal year 2021 guidance projecting that Helen of Troy will cross the $2 billion sales milestone for the first time and grow its adjusted EPS by $2.20 per share.

Helen of Troy Limited reported excellent first quarter results with a consolidated net sales growth of 11.8% and adjusted diluted EPS growth of 22.8%. The Health & Home segment led the way with sales growth of 29%.

Helen of Troy reported a 14.9% increase in consolidated net sales revenue, driven by growth in Leadership Brands and online channels. However, the company experienced a GAAP operating loss due to non-cash asset impairment charges. Adjusted diluted EPS from continuing operations increased by 3.3% to $1.88.

Helen of Troy reported a strong third quarter with a 10.1% increase in consolidated net sales and a 30.0% increase in adjusted diluted EPS. The company is raising its sales and adjusted EPS outlook for the fiscal year.